Diabetes-Focused Insulet Forecasts Strong 2026 Growth, Stock Soars

Insulet Corporation (NASDAQ:PODD) stock is trading higher on Wednesday after the company reported better-than-expected fourth-quarter earnings and 2026 guidance.Fourth-quarter adjusted earnings reached $1.55 per share, beating the consensus of $1.45.The automated insulin delivery technology maker reported sales of $783.8 million, up 31.2% year over year or 29% in constant currency (CC), beating the consensus of $768.69 million, exceeding the high end of the company's guidance range of 25% to 28% in constant ...